BELLEVUE MEDICAL CENTER — History
CCN 280132 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$113M
Latest Revenue (FY2022)
+18.2%
Revenue CAGR (3yr)
11.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $81M | $105M | $113M | +7.9% | +18.2% |
| Operating Expenses | $67M | $83M | $100M | +20.2% | +21.9% |
| Operating Margin | 16.4% | 20.2% | 11.2% | -44.9% | -17.5% |
| Net Income | $13M | $21M | $13M | -40.5% | -2.4% |
| Licensed Beds | 63 | 44 | 69 | +56.8% | +4.7% |
| Total Patient Days | 12,407 | 14,428 | 17,406 | +20.6% | +18.4% |
| Medicare Day % | 48% | 49% | 46% | -5.8% | -2.2% |
| Medicaid Day % | 1% | 2% | 1% | -14.6% | -1.6% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +39.8% ($81M → $113M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+18.2%
This Hospital
+7.6%
State Avg
Latest Margin
11.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $129M | 8.5% |
| FY2024 (proj) | $145M | 5.9% |
| FY2025 (proj) | $161M | 3.3% |